Vera Therapeutics Inc (VERA)
43.75
+0.31
(+0.71%)
USD |
NASDAQ |
May 06, 13:22
Vera Therapeutics Market Cap: 2.382B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 2.365B |
May 02, 2024 | 2.369B |
May 01, 2024 | 2.304B |
April 30, 2024 | 2.151B |
April 29, 2024 | 2.253B |
April 26, 2024 | 2.159B |
April 25, 2024 | 2.107B |
April 24, 2024 | 2.175B |
April 23, 2024 | 2.152B |
April 22, 2024 | 2.131B |
April 19, 2024 | 2.069B |
April 18, 2024 | 2.150B |
April 17, 2024 | 2.179B |
April 16, 2024 | 2.318B |
April 15, 2024 | 2.534B |
April 12, 2024 | 2.612B |
April 11, 2024 | 2.658B |
April 10, 2024 | 2.266B |
April 09, 2024 | 2.064B |
April 08, 2024 | 2.103B |
April 05, 2024 | 2.043B |
April 04, 2024 | 2.037B |
April 03, 2024 | 2.156B |
April 02, 2024 | 2.224B |
April 01, 2024 | 2.306B |
Date | Value |
---|---|
March 28, 2024 | 2.348B |
March 27, 2024 | 2.387B |
March 26, 2024 | 2.264B |
March 25, 2024 | 2.242B |
March 22, 2024 | 2.233B |
March 21, 2024 | 2.334B |
March 20, 2024 | 2.468B |
March 19, 2024 | 2.364B |
March 18, 2024 | 2.258B |
March 15, 2024 | 2.323B |
March 14, 2024 | 2.336B |
March 13, 2024 | 2.429B |
March 12, 2024 | 2.373B |
March 11, 2024 | 2.319B |
March 08, 2024 | 2.379B |
March 07, 2024 | 2.326B |
March 06, 2024 | 2.464B |
March 05, 2024 | 2.425B |
March 04, 2024 | 2.500B |
March 01, 2024 | 2.639B |
February 29, 2024 | 2.529B |
February 28, 2024 | 2.467B |
February 27, 2024 | 2.585B |
February 26, 2024 | 2.489B |
February 23, 2024 | 2.548B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
150.40M
Minimum
Jan 09 2023
2.658B
Maximum
Apr 11 2024
652.09M
Average
494.24M
Median
Dec 12 2022
Market Cap Benchmarks
Vertex Pharmaceuticals Inc | 104.31B |
Alpine Immune Sciences Inc | 4.234B |
Fate Therapeutics Inc | 412.83M |
Mersana Therapeutics Inc | 430.10M |
Equillium Inc | 63.81M |
Market Cap Related Metrics
Price to Book Value | 23.43 |
Price | 43.75 |
Earnings Yield | -5.23% |